ペンシルバニア州スプリングハウス、2026年1月6日 – Johnson & Johnson（以下「J&J」）は、本日、全身性エリテマトーデス（systemic lupus erythematosus: ...

Our most recent episode of The Expert Series podcast explores the newly released SLE treatment guidelines and how they might affect patient care.

The FDA has granted breakthrough therapy designation for litifilimab in patients with cutaneous lupus erythematosus, ...

New findings from a Phase II study indicate that antenatal treatment with the FcRn blocker nipocalimab resulted in low fetal drug exposure and transient reductions in infant IgG levels at birth, ...

A treatment that restores normal kidney function in almost half of patients with lupus nephritis has been approved by the National Institute for Health and Care Excellence (NICE). Obinutuzumab ...

PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) has awarded nearly $1 million in grant funding to nonprofit organizations across the United States aimed at improving diagnosis, treatment, and long-term ...

How would you treat a 30-year-old woman with systemic lupus erythematous (SLE) and lupus nephritis (LN) class 3 with new ...

Biogen BIIB announced that the FDA has granted the Breakthrough Therapy designation to its investigational, first-in-class, ...

Designation is based on the breadth of available litifilimab data, including the Phase 2 LILAC study result that showed ...

SEN. Bong Go has hailed the approval on third and final reading of Senate Bill (SB) 1513, or the proposed Comprehensive Lupus ...